Faron Pharmaceuticals Oy (FARN.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In GBp
| Market Cap | 222.03M |
| Enterprise Value | 234.39M |
| P/E Ratio | -3.26 |
| PEG Ratio | -1.83 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 5.48 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.67 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.46 |
| Return On Equity | 4.76 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -325,893 |
| EBITDA | -19.93M |
| Net Income | -27.25M |
| Diluted EPS | -0.25 |
| Total Cash | 32.15M |
| Total Cash/Share | 0.21 |
| Total Debt | 17.92M |
| Total Debt/Equity | 1.54 |
| Current Ratio | 2.4 |
| Book Value Per Share | 0.08 |
| 52-Week Change | -80 |
| 52-Week High | 210 |
| 52-Week Low | 33.5 |
| Moving Average 50 Days | 37.22 |
| Moving Average 200 Days | 54.77 |
| Average Volume | 62,118 |
| Shares Outstanding | 202.88M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 151:125 |
| Last Split Date | June 04, 2024 |